531686
ADVIKLA
Start SIP
Invest Now
Start SIP in ADVIKLA
Performance
- Low
- ₹2
- High
- ₹2
- 52 Week Low
- ₹2
- 52 Week High
- ₹4
- Open Price₹2
- Previous Close₹2
- Volume1,917
- 50 DMA₹2.44
- 100 DMA₹2.64
- 200 DMA₹2.49
Investment Returns
- Over 1 Month -5.08%
- Over 3 Month -18.84%
- Over 6 Month -38.24%
- Over 1 Year -60.1%
Smart Investing Starts Here Start SIP with MPS Pharma for Steady Growth!
MPS Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -3.6
- PEG Ratio
- -4
- Market Cap Cr
- 3
- P/B Ratio
- 5
- Average True Range
- 0.09
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.26
- RSI
- 23.98
- MFI
- 17.05
MPS Pharma Financials
MPS Pharma Technicals
EMA & SMA
Current Price
₹1.68
-0.08
(-4.55%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1.98
- 50 Day
- ₹2.44
- 100 Day
- ₹2.64
- 200 Day
- ₹2.49
Resistance and Support
1.71
- R3 1.81
- R2 1.79
- R1 1.73
- S1 1.65
- S2 1.63
- S3 1.57
MPS Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-09-02 | A.G.M. | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-28 | Audited Results | |
| 2025-02-12 | Quarterly Results |
MPS Pharma F&O
About MPS Pharma
- NSE Symbol
- ADVIKLA
- BSE Symbol
- 531686
- Managing Director
- Mr. Peeyush Kumar Aggarwal
- ISIN
- INE537C01019
Similar Stocks to MPS Pharma
MPS Pharma FAQs
MPS Pharma share price is ₹1 As on 17 January, 2026 | 17:58
The Market Cap of MPS Pharma is ₹3.2 Cr As on 17 January, 2026 | 17:58
The P/E ratio of MPS Pharma is -3.6 As on 17 January, 2026 | 17:58
The PB ratio of MPS Pharma is 5 As on 17 January, 2026 | 17:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.